Steve Damment
Oprichter bij Aluztura Bio Ltd.
Profiel
Steve Damment is the founder of Aluztura Bio Ltd.
which is founded in 2014, where he holds the title of Chief Science Officer.
He held the position of Senior Vice President-Biosciences at Shire Plc from 2000 to 2013 and at GSK Plc from 1982 to 1999.
He also held the position of Executive Vice President-Research & Development at Biodexa Pharmaceuticals Plc from 2018 to 2021.
Dr. Damment received his undergraduate degree from The University of Liverpool.
Actieve functies van Steve Damment
| Bedrijven | Functie | Begin |
|---|---|---|
| Aluztura Bio Ltd. | Oprichter | 01-01-2014 |
Eerdere bekende functies van Steve Damment
| Bedrijven | Functie | Einde |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Hoofd Techniek/Wetenschap/O&O | 30-09-2021 |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Corporate Officer/Principal | 01-12-2013 |
| GSK PLC | Corporate Officer/Principal | 01-12-1999 |
Opleiding van Steve Damment
| The University of Liverpool | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| GSK PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
| Aluztura Bio Ltd. |
